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Abstract
Background: Patient, public, consumer, and community (P2C2) engagement in organization-, community-, and system-
level healthcare decision-making is increasing globally, but its formal evaluation remains challenging. To define a taxonomy 
of possible P2C2 engagement metrics and compare existing evaluation tools against this taxonomy, we conducted a 
systematic review.
Methods: A broad search strategy was developed for English language publications available from January 1962 through 
April 2015 in PubMed, Embase, Sociological Abstracts, PsycINFO, EconLit, and the gray literature. A publication was 
excluded if: (1) the setting was not healthcare delivery (ie, we excluded non-health sectors, such as urban planning; research 
settings; and public health settings not involving clinical care delivery); (2) the P2C2 engagement was episodic; or (3) the 
concept of evaluation or possible evaluation metrics were absent. To be included as an evaluation tool, publications had to 
contain an evaluative instrument that could be employed with minimal modification by a healthcare organization.
Results: A total of 199 out of 3953 publications met exclusion and inclusion criteria. These were qualitatively analyzed using 
inductive content analysis to create a comprehensive taxonomy of 116 possible metrics for evaluating P2C2 engagement. 
44 outcome metrics were grouped into three domains (internal, external, and aggregate outcomes) that included six 
subdomains: impact on engagement participants, impact on services provided by the healthcare organization, impact on 
the organization itself, influence on the broader public, influence on population health, and engagement cost-effectiveness. 
The 72 process metrics formed four domains (direct process metrics; surrogate process metrics; aggregate process metrics; 
and preconditions for engagement) that comprised sixteen subdomains. We identified 23 potential tools for evaluating 
P2C2 engagement. The identified tools were published between 1973-2015 and varied in their coverage of the taxonomy, 
methodology used (qualitative, quantitative, or mixed), and intended evaluators (organizational leaders, P2C2 participants, 
external evaluators, or some combination). Parts of the metric taxonomy were absent from all tools.
Conclusions: By comprehensively mapping potential outcome and process metrics as well as existing P2C2 engagement 
tools, this review supports high-quality P2C2 engagement globally by informing the selection of existing evaluation tools 
and identifying gaps where new tools are needed. 
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Introduction
Ensuring that individuals and communities are engaged 
in healthcare decision-making is now widely regarded as a 
requirement of patient centered care. One part of engagement, 
enshrined as a right of all people in the 1978 Declaration 
of Alma-Ata,1 requires engaging patients not only in their 
own individual medical decisions but also in the design 
and implementation of healthcare services.2,3 This type of 
engagement is occurring globally. In the United States, some 
jurisdictions require patient and family advisory councils to 
inform individual hospital governance,4 major healthcare 
reform efforts require patient representation on governance 
boards,5 and many healthcare organizations and systems 
see patient engagement as the right thing to do (a recurring 
theme since at least the 1970s).6-9 In the United Kingdom,10-12 
Canada,13-15 Australia,16,17 and New Zealand,18 there has also 
been systematic public involvement in healthcare decision-
making via regional or local health advisory councils, 
committees, boards or citizen juries. Public engagement 
in health sector priority-setting has also been mandated or 
promoted in low- and middle-income countries.19-22
Despite increasing attention to patient engagement in the 
design and implementation of healthcare services, there is 
both a greater need for formal engagement evaluation23 and 
little agreement on how to do so. Existing how-to guides 
suggest that patient engagement can contribute positively to 
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health outcomes, reduce unnecessary costs, or increase trust 
in healthcare organizations,24,25 but real evidence of these 
impacts, according to literature reviews, is lacking.26-28 A 2010 
review of engagement in healthcare policies and programs 
concluded that existing evaluations narrowly focus on short-
term impact and proxy or surrogate measures of perceived 
impact.29
Given the evidence gap and the need to update existing 
reviews, we conducted a systematic review of metrics to 
evaluate patient, public, consumer and community (P2C2) 
engagement in organization-, community-, and system-
level healthcare decision-making. We defined P2C2 
engagement as a continuous systematic effort to incorporate 
the needs, values, and preferences of the P2C2 engagement 
participants into decision-making. Though there may be 
differences between patients, the public, consumers, and the 
community in concept, in practice healthcare organizations 
may use the terms interchangeably when engaging those 
stakeholders in decision-making, and our focus was upon 
what is common to all those engagement activities – namely, 
the goal of incorporating those stakeholders’ needs, values 
and preferences. In those activities, P2C2 engagement 
participants are involved as stakeholder representatives of 
their constituents, rather than as individuals. This review 
focuses on engagement in organization-, community-, and 
system-level healthcare decision-making as distinct from 
patient engagement in their individual personal medical 
decisions.2,3 Our objectives were (1) to create a taxonomy 
of possible P2C2 engagement evaluation metrics using an 
inductive qualitative analysis of the literature and then (2) to 
compare existing P2C2 engagement evaluation tools against 
this taxonomy. 
Methods
Identification of Publications
The nature of our subject matter required a broad search 
strategy within the published and gray literature. We 
conducted a search for publications available in English from 
January 1, 1962 through April 20, 2015 in PubMed, Embase, 
Sociological Abstracts, PsycINFO, and EconLit with Full 
Text. Terminology surrounding P2C2 “engagement” may be 
imprecise; therefore, we designed our search to cast a wide 
net, then relied upon our inclusion/exclusion criteria to 
identify target publications. Search terms were identified via 
consultations with an informationist and through an iterative 
process of search yield analyses. The final search included 
three concept blocks: (1) P2C2 engagement; (2) decision-
making; and (3) healthcare planning. 
The first block included 125 search terms, which combined 
(i) “patient,” “consumer,” “stakeholder,” “community,” “public,” 
and related words with (ii) “engagement,” “participation,” 
“involvement,” “representation,” “advocacy,” and related words. 
The second block included 40 search terms, such as “decision-
making,” “clinical governance,” “policy-making,” “governing 
board,” “participatory management,” and related words. 
The third block included 61 search terms, which combined 
(i) “healthcare,” “health,” and “medical” with (ii) “system,” 
“organization,” “planning,” “priority,” and related words. For 
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3953 Unique publications identified through database search 
for abstract screening  
3497 excluded:  
541 Setting is not healthcare organization or 
administration  
266 Engagement in research settings 
786 No P2C2 are engaged in priority-setting 
or decision-making  
1520 Engagement is not at organization-, 
community- or system-level 
192 Engagement is not a systematic process  
190 Non-English language 
2 No full-text version 
456 publications retained for 
screening in full-text 
398 excluded: 
21 Setting is not healthcare organization or 
administration  
6 Engagement in research settings 
128 No P2C2 are engaged in priority-setting 
or decision-making 
14 Engagement is not at organization-, 
community- or system-level 
32 Engagement is not a systematic process  
16 No evaluation of engagement attempted 
60 General evaluation only - no metrics  
67 Metric is insufficiently described  
17 Non-English language 
37 No full-texts 
 
 
Figure 1. Flow Diagram Describing Publication Selection 
44 publications from 
references selected for 
screening in full-text 
 
97 grey literature 
publications selected for 
screening in full-text 
 
199 publications qualitatively analyzed to 
develop taxonomy 
Among these, 21 publications 
containing 23 evaluation tools  
all three concept blocks we included corresponding controlled 
vocabulary items relevant to the particular database. To be 
included, a publication had to contain at least one term or 
controlled vocabulary item from each block. Full details of 
the search strategy are included in online Supplementary file 
1. After combining all database search results and removing 
duplicates, this search yielded 3953 possible publications. 
Gray literature publications were identified throughout May 
2015–July 2016 from sources identified during review of 
the published literature and via a similar search strategy of 
select websites. The 32 targeted websites of relevant national 
and international organizations are included in online 
Supplementary file 2. The gray literature search yielded 97 
additional possible publications. 
Lastly, during our full text review, in reference lists we 
identified 44 additional possible publications which were 
reviewed in full-text. This systematic review was included 
on May 7, 2015 in the International Prospective Register 
of Systematic Reviews (PROSPERO), registration number 
CRD42015020317.
Criteria for Selection
Figure 1 describes the publication selection process. We 
excluded publications whose language was not in English or 
whose publication type did not provide a full-text version. 
We included publications if their setting was healthcare 
administration or healthcare organization in clinical settings. 
Figure 1. Flow Diagram Describing Publication Selection.
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A publication was excluded if the setting was (1) outside the 
healthcare sector (eg, urban planning, environmental services, 
and education sectors, among others, would be excluded); (2) 
research; or (3) outside of clinical care delivery (eg, public 
health and/or health promotion programs). Moreover, to be 
included, publications needed to contain a description of 
P2C2 engagement in decision-making at the organizational-, 
community-, or system-level; thus, we excluded publications 
describing engagement exclusively related to personal 
medical decisions. Since we also required engagement to be 
a continuous systematic process (as opposed to episodic or 
one-off engagement), we excluded publications that did not 
reference more than one instance of engagement.
First, two reviewers (either VD and RT or VD and MD) 
independently screened abstracts by applying these exclusion 
and inclusion criteria. Inter-reviewer disagreement was 
resolved through discussion involving the third reviewer 
(either MD or RT). If inclusion or exclusion could not be 
determined based on an abstract alone, the publication 
was retained for full-text review. Next, the same selection 
procedure and criteria were applied for full-text review. 
Final inclusion eligibility was dependent on the presence of 
evaluation of engagement, either via a sufficiently detailed 
definition of a possible measure or via a discrete measure itself. 
In total 199 publications were retained for this review.
Among these 199, reviewers noted any publications 
that included an evaluation tool. We defined a tool as a 
questionnaire, survey, or other evaluative device that a 
healthcare organization or system could be used with no or 
minimal modification to evaluate P2C2 engagement efforts. 
We identified 21 publications containing 23 evaluation tools. 
Developing a Taxonomy of Metrics From the Literature
When reviewing the 199 publications, reviewers 
independently annotated each publication for the presence 
of evaluation metrics. This was done descriptively, via an 
editing style of qualitative content analysis.30-32 A reviewer 
would read the publication in its entirety, highlighting text 
descriptions of possible evaluation metrics. The reviewer 
would then inductively apply a descriptive annotation (or 
“code”) of what the evaluation metric intended to measure. 
To illustrate, if a publication referenced measuring P2C2 
participants’ “improved knowledge of the healthcare system,” 
this would be descriptively annotated as “knowledge” metric. 
Next, thematic analysis was used to combine and group 
similarly themed annotations into one list. Finally, using the 
accepted distinction between process and outcome metrics 
in healthcare evaluation, the research team (VD, RT, MD) 
discussed and reorganized the list into a taxonomy of possible 
metrics, grouping thematically-related metrics into domains 
and subdomains of process and outcome categories.
Applying the Taxonomy to Evaluation Tools
Subsequently, VD and MD, in collaboration, conducted a 
second qualitative analysis of the included evaluation tools 
using NVivo Plus (QSR International Pty Ltd, Version 11, 
2016). Each tool’s questions or survey items were coded 
according to the taxonomy: firstly, (1) into the process or 
outcome category; secondly (2) into the metric subdomain, 
and thirdly (3) as a specific metric within that subdomain. If 
a question or item was non-specific and could not be coded 
in steps (2) or (3), it was coded only into the broader category 
or subdomain. Items could be coded more than once, and 
coding frequencies were tracked. Based on the resulting 
frequency histogram, frequencies were transformed into a 
categorical scale (categories: 1-3 instances, 4-14 instances, 
or 15 or more instances of coding). Evaluation tools were 
also descriptively characterized by country, publication date, 
method of evaluation (quantitative, qualitative or mixed), 
intended evaluators (leaders, P2C2 representatives, both 
leaders and representatives, or external evaluators) and setting 
(healthcare program, individual hospital, healthcare system 
agency and others). Due to the nature of extracted data, 
standard procedures to assess quality of studies reporting the 
metrics or tools were not applicable.
Results
Overview of the Included Publications
We identified 199 eligible publications, which were 
qualitatively analyzed to create a taxonomy of possible metrics 
of P2C2 engagement in healthcare organization-, community-, 
and system-level decision-making. Of these, 21 presented 
23 distinct evaluation tools.33-53 The characteristics of these 
evaluation tools are in Table 1 (the remaining 178 publications 
are listed in the online Supplementary file 3).
Identified tools were published between 1973 and 2015. 
Twelve out 23 were implemented in the United States, three 
in Canada, three in the United Kingdom, two in Nepal, 
and the rest were implemented once in other low-middle-
income (Djibouti, Honduras, South Africa, or Tanzania) or 
high-income countries (Ireland or New Zealand). Thirteen 
tools used mixed method evaluation, six only quantitative 
evaluation and one only qualitative evaluation. The evaluation 
was filled out by patient, public, consumer, and community 
(P2C2) representatives in one tool, by organization leaders in 
seven tools, by both representatives and leaders in nine tools, 
and by external evaluators in six tools. The tools were used in 
diverse settings, from individual hospitals to health systems 
and programs. 
Taxonomy of Metrics 
We organized metrics of P2C2 engagement into two main 
categories: outcome metrics and process metrics.54 Within each 
category we identified subdomains which we subsequently 
clustered into domains based on thematic relatedness. Figure 
2 illustrates the taxonomy’s domains and subdomains within 
the categories. Please refer to online Supplementary file 4 
for the full taxonomy with metrics forming each subdomain 
listed.
Outcome Metrics
We identified 44 unique outcome metrics forming six distinct 
subdomains. Further, we clustered related subdomains into 
three domains: (i) internal outcomes, (ii) external outcomes, 
and (iii) aggregate outcomes. ‘Internal outcomes’ were 
those subdomains containing metrics most relevant to, and 
Dukhanin et al
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Table 1. Listing of Identified Evaluation Tools and their Basic Characteristics
Tool Name (If Applicable), Authors Country Year Setting Method of 
Evaluation
Brief Description
Who Fills Out 
Evaluation
Metsch and Veney33 USA 1973 Individual hospital Quantitative Scoring tool for meeting minutes that assigns weighted categories of 
interaction for each consumer recommendation.
External evaluators
Steckler and Dawson34 USA 1978 Health Systems Agency Quantitative 38 questions in five items/indices and interview data. Adapted fromi-iv. Leaders and P2C2 
representatives
Rifkin, Muller, and Bichmann35 Nepal 1988 Healthcare program Quantitative Qualitative data scored 1 to 5 in five dimensions using a ranking table. External evaluators
Schmidt and Rifkin36
Tanzania 1996 Healthcare program Quantitative Same tools as #3 applied in a different country. External evaluators
Consumer Participation Questionnaire,  Kent 
and Read37
New Zealand 1998 Mental health services Mixed method Yes/No, Likert scale, and discrete choice items. Leaders
El Ansari and Phillips38
South Africa 2001 Healthcare program Quantitative 7-point Likert scale covering eight dimensions. Derived from sources evaluating 
engagement outside healthcare.
Leaders and P2C2 
representatives
Partnership self-assessment survey, Shortell 
et al39 USA 2002 Diverse Quantitative 5-point Likert scale items. Four components are measured using 1-5 items.
Leaders and P2C2 
representatives
Halliday et al40
UK 2004 Diverse Mixed method
4-point Likert scale (covering nine dimensions) and open-ended questions. 
Derived fromv-vi.
Leaders and P2C2 
representatives
Jarrett and Patient Involvement Unit41 UK 2004
Guideline development 
group
Mixed method
5-point Likert scale and interview questions in open-ended fashion, both 
evaluating the same aspects.
Leaders and P2C2 
representatives
A Hospital Self-Assessment Inventory.
Institute for Family-Centered Care42
USA 2004 Individual hospital Mixed method 5-point Likert scale, and 3-point rating system and open-ended notes. Leaders and P2C2 
representatives
Well Connected, South et al43 UK 2005 Healthcare program Quantitative
10-point scale covering six dimensions based on three general scoring criteria. 
Drawn from tool #3 and vi-viii.
Leaders and P2C2 
representatives
Grant44 Canada 2007 Mental health services Mixed method Yes/No questions, Likert scale questions, and multiple choice items. Modified 
by adding questions to tool #4. 
Leaders
Evaluation Form, Health and Social Care 
Regulatory Forum45
Ireland 2009 Diverse Mixed method 5-point Likert and open-ended questions. Derived fromix. Leaders
Draper et al46
Djibouti, 
Honduras, 
and Nepal
2010 Healthcare program Quantitative 5-point scale scoring five factors (tool provides example descriptions for 1-, 3-, 
and 5-point scores). Modified #3, by replacing two domains.
External evaluators
PFAC Annual Report Template, Consumer 
Health Quality Council HCFA, Massachusetts47
USA 2012 Individual hospital Qualitative Open-ended items and multiple-choice questions. Leaders
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Consumer Health Quality Council Review 
Instrument for 2011 Reports, Consumer Health 
Quality Council HCFA, Massachusetts47
USA 2012 Individual hospital Mixed method Open-ended, multiple choice and Yes/No questions. External evaluators
National Institute for Children's Health Quality48 USA 2012 Diverse Mixed method 3-point Likert scale questions with “free-text” field and a set of 5-point Likert 
scale questions. Derived from Essential Allies.25 Leaders
HCFA Recommended 2013 PFAC Annual Report 
Template HCFA, Massachusetts49
USA 2014 Individual hospital Mixed method Multiple-choice and open-ended questions. Leaders and P2C2 
representatives
HCFA 2013 PFAC Report Review Tool, HCFA, 
Massachusetts49
USA 2014 Individual hospital Mixed method Open-ended, multiple choice and Yes/No questions. External evaluators
PFAC Council Evaluation. Brigham and Women’s 
Hospital Center for Patients and Families50
USA 2014 Individual hospital Mixed method 5-point Likert scale and open-ended questions. Leaders and P2C2 
representatives
PPEET, Participant questionnaire, v. 1.0. Abelson 
and PPEET Research-Practice Collaborative51
Canada 2015 Diverse Mixed method 5-point Likert scale plus open-ended questions. P2C2 representatives
PPEET, Organization questionnaire, v. 1.0. 
Abelson and PPEET Research-Practice 
Collaborative51
Canada 2015 Diverse Mixed method 5-point Likert scale plus open-ended questions. Leaders
CCP evaluation framework, CCP Steering 
Committee52
USA 2015 Medicaid Managed Care Quantitative Review of program websites and documents with Yes/No checkboxes. External evaluators
National ACO Patient Activation and 
Engagement Survey, Shortell et al53
USA 2015 ACO Quantitative 1 to 9 Likert scale and Yes/No items. Part of the National Survey of ACOs. Leaders
Abbreviations: ACO, accountable care organization; CCP, Consumer Confidence Project; HCFA, Health Care For All; P2C2, patient, public, consumer and community; PFAC, Patient and Family Advisory Council; PPEET, Public and Patient 
Engagement Evaluation Tool. 
References that appear only in Table 1: 
i. Beck A, Bishop P. The Consumer Support Group: A Report to the Board of Trustees, Capitol Area Comprehensive Health Planning Association. Lansing, Michigan, 1973. 
ii. Douglass C. Representation patterns in community health decision-making. J Health Soc Behav 1973;14(1):80-86. doi:10.2307/2136939.
iii. Douglass C. Effect of provider attitudes in community health decision-making. Med Care 1973;11(2):135-144.
iv. Douglass C. Health Services Planning in the Urban Ghetto: A Comparative Analysis of Eight Model Cities Programs [dissertation]. University of Michigan School of Public Health, Ann Arbor, 1971.
v. Hardy B, Hudson B, Waddington E. What Makes a Good Partnership? A Partnership Assessment Tool. Leeds: Nuffield Institute for Health, Community Care Division, 2000.
vi. World Health Organization/Health Education Board for Scotland. Verona Benchmark: Guide to the Assessment of Good Practice within Partnership Working. 2000.
vii. Yorkshire Forward. Active Partners. Benchmarking Community Participation in Regeneration. Leeds: Yorkshire Forward, 2000. 
viii. Funnell R, Olfield K, Speller V. Towards Healthier Alliances: A Tool for Planning, Evaluating and Developing Healthy Alliances. London: Health Education Authority, Wessex Institute for Health, 1995. 
ix. Irish Society for Quality and Safety in Healthcare and Health Care Informed. Now We’re Talking: A practical toolkit for public and patient involvement in healthcare. Dublin: Irish Society for Quality and Safety in Healthcare, 2009.
Table 1. Continued
Tool Name (If Applicable), Authors Country Year Setting Method of 
Evaluation
Brief Description
Who Fills Out 
Evaluation
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evaluated within, a healthcare organization or system. This 
domain included three subdomains: impact on engagement 
participants themselves (eg, improved knowledge among 
P2C2 participants), impact on the services provided by the 
organization or system (eg, improved quality or decreased 
utilization of services), and impact on the organization or 
system (on its policies, procedures or resources, eg, redesign 
of staff roles, or staff training policies, or expanding its patient 
engagement program). 
By contrast, ‘external outcomes’ were those subdomains 
containing metrics most relevant beyond the organization 
or system itself and requiring evaluation outside the 
organization. This group included two subdomains: influence 
on the broader public (eg, strengthened public support of the 
organization) or on population health generally (eg, decreased 
health inequalities).
Finally, we kept cost effectiveness of engagement as a separate 
‘aggregate outcome’ domain since the overall cost-effectiveness 
from the standpoint of the healthcare organization or system 
could take into account all changes (positive or negative) 
throughout all subdomains. 
Process Metrics
We identified 72 unique process metrics forming 16 
subdomains. We clustered related subdomains into four 
domains: (i) direct process metrics; (ii) surrogate process 
metrics; (iii) preconditions for engagement metrics; and (iv) 
aggregate process metrics.
‘Direct process metrics’ included subdomains that describe 
the degree of real control that P2C2 participants have over 
the decision-making process. For instance, whether P2C2 
participants set the agenda, have well-defined roles, or are 
able to evaluate and revise the decision process itself are all 
metrics that could be considered as those of direct control 
over the process. Other examples of such metrics are whether 
P2C2 participants are involved in the decision process since 
its first stages, or P2C2 participants are included in all types 
of decisions and activities, or P2C2 participants are allowed 
the opportunity to finalize the decisions. 
By contrast, the domain of ‘surrogate process metrics’ does 
not evaluate direct control over decision-making. Instead, 
surrogate process metrics describe formal attributes of the 
process. For instance, whether P2C2 participants hold certain 
formal positions within the organization, have veto power, or 
are financially independent of the organization are all metrics 
of formal attributes that could correlate with direct process 
control. Attendance of the meetings by P2C2 participants is 
another example of a surrogate metric in the participation 
subdomain. Surrogate process metrics also included metrics 
related to the organizational commitment to engagement, 
such as the presence of a formal declaration of support for 
engagement, and metrics identifying whether engagement is 
tailored to P2C2 participants’ needs or beliefs. 
‘Preconditions for engagement metrics’ included subdomains 
of factors necessary for engagement.55 Relevant subdomains 
included metrics covering the type of recruitment process 
used to identify P2C2 participants, whether resources (eg, 
parking, transportation, and/or meals) are provided to the 
P2C2 participants, whether training is provided to P2C2 
participants or organizational staff, P2C2 participants’ 
representativeness and accountability to their constituents, 
and whether engagement was initiated by P2C2. For instance, 
under the subdomain of representativeness, metrics could 
evaluate whether P2C2 participants are representative of their 
relevant constituency (eg, a disease group), democratically 
represent a broader community, or explicitly represent 
minority, vulnerable or marginalized groups.
Finally, ‘aggregate process metrics’ included subdomains of 
metrics that evaluate cross-domain aspects of engagement 
and provide an overall summary assessment as a result. For 
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PROCESS METRICS 
 
Internal outcomes, as impact on: 
Engagement participants 
Services provided 
Organization or system  
 
 
 
 
 
External outcomes, as influence on: 
Broader public  
Population health 
 
 
 
 
 
Aggregate outcome 
Overall cost-effectiveness of 
engagement  
 
 
 
 
 
Figure 2. Taxonomy of metrics: metrics categories, domains and subdomains 
For the full taxonomy with listed metrics forming each subdomain, please refer to Online 
Supplementary Material 4 
Direct process metrics 
P2C2 participants’ control over 
decision process 
 
 
 
 
 
Surrogate process metrics 
Formal power  
Organizational commitment to 
engagement 
Participation  
Tailoring the engagement to P2C2 
participants’ needs  
 
 
 
 
 
 
Aggregate process metrics 
Respect 
Transparency of decision-making 
Trust 
Legitimacy of decision-making 
Level of participation 
 
 
 
 
 
 
Preconditions for engagement metrics 
P2C2-initiated engagement 
Recruitment and membership 
Representativeness and 
accountability 
Resources provided to P2C2 
participants 
Training for P2C2 participants 
Training for staff 
 
Figure 2. Taxonomy of Metrics: Metrics Categories, Domains and Subdomains. For the full taxonomy with listed metrics forming each subdomain, please 
refer to online Supplementary file 4.
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instance, metrics of trust draw upon different aspects of the 
preconditions, surrogate measures, and direct measures of the 
engagement process. 
Results of Coding Evaluation Tools According to the Taxonomy 
Outcome Metrics
Among 23 identified tools (introduced in Table 1), 13 
included at least one question or item coded as an outcome of 
P2C2 engagement (Table 2). The entire taxonomy contains 44 
unique outcome metrics; 22 of these were identified in at least 
one question or item within a tool. Internal outcomes were 
more frequently coded than external outcomes.
Individual tools varied in their coverage of outcome metrics, 
ranging from one item addressing a general outcome 
measure to 32 coding instances when a tool’s questions or 
items included all six outcome metric subdomains. Six tools 
included four or more instances of coded outcome metrics. 
Among the five of these containing 4-14 coding instances, 
internal outcomes were predominant. All six were designed 
to be filled out by both leaders and P2C2 representatives 
(including two separately coded tools that comprise one 
inventory51).
Process Metrics
All 23 identified tools included at least one question or item 
coded as a process metric of engagement (Table 3). Fifty-six of 
the 72 unique process metrics described in the taxonomy were 
present in at least one tool. Direct process metrics evaluating 
P2C2 control over decision process were identified in every 
tool. Surrogate process metrics addressing organizational 
commitment to engagement and participation as well as 
metrics of preconditions for engagement (ie, resources 
provided to P2C2 participants), were the most frequent 
process metrics.
Individual tools varied in their coverage of process metrics, 
ranging from one tool that included three instances in 
three metric subdomains to another tool that included 41 
instances within six subdomains of process metrics. Seven 
tools included 15 or more instances of coded process metrics. 
Five of them were designed to be filled out by both leaders 
and P2C2 representatives and the remaining two by the 
leaders only. For those seven tools, the most frequently coded 
subdomains followed the same pattern identified for all the 
tools.
Thirteen tools included both process and outcomes metrics; 
three of these tools contained 4-14 instances of outcome 
metrics and 15 or more instances of coded process metrics. 
All of these three tools were designed to be filled out by both 
leaders and P2C2 representatives.
Discussion
This systematic review of metrics for evaluating P2C2 
engagement in healthcare organization-, community-, 
and system-level decision-making produced the following 
principal findings. First, from our qualitative analysis, 
we developed a comprehensive taxonomy of 116 possible 
engagement metrics grouped into distinct domains and 
subdomains. Second, we identified 23 tools that could be used 
to evaluate P2C2 engagement. There was no perfect tool: they 
varied in their coverage of the taxonomy, in the method used 
(ie, qualitative versus quantitative) and intended evaluators 
(leaders, P2C2 representatives, or both, or, alternatively, 
external experts). Third, parts of the metric taxonomy were 
absent from all tools. 
Taxonomy of Metrics
The developed taxonomy illustrates that the literature on 
P2C2 engagement describes a large variety of possible 
process and outcome metrics. Perhaps reflecting an emphasis 
on engagement as itself a process, nearly twice as many 
process metrics (72) were identified compared to outcome 
metrics (44). Among outcome metrics, more addressed 
internal outcomes (ie, the effect of P2C2 engagement on the 
organization itself, its services, or engagement participants) 
than external outcomes (ie, the effect of engagement beyond 
the organization where it occurs). 
Among process metrics, we identified four domains of 
surrogate process metrics. However, analogous to health 
measures – where surrogate metrics may or may not evaluate 
the clinically significant endpoint – surrogate engagement 
process metrics, such as attendance or formal organizational 
commitment to engagement, may or may not evaluate the 
engagement process meaningfully. 
Finally, among process metrics inquiring into preconditions 
necessary for engagement process, representativeness and 
accountability constitute a unique measurement challenge. 
Deciding on theoretical constructs of representativeness 
and representatives’ accountability and then translating 
those constructs into a feasible evaluation involving, if 
needed, the constituents themselves, will require complex 
multidisciplinary solutions.
For both process and outcomes metrics, aggregate metrics, 
such as whether P2C2 participants feel generally respected in 
the engagement process, may be useful as starting points but 
provide little insight into why this is the case or how to improve 
the P2C2 engagement. Similarly, evaluations employing a 
general ladder of participation approach56 (which ranges from 
“manipulation” of P2C2 participants by the organization to 
“partnership” to complete P2C2 “control” over the process) 
may guide an overall engagement approach but fail to provide 
specific actionable feedback on engagement. 
Our taxonomy was developed inductively and has similarities 
and differences with prior taxonomies or frameworks.57 
It similarly includes subdomains of transparency, 
representativeness, and resource support, and attention 
to P2C2 participants’ control over the decision process 
(including their early involvement and independence in 
decision-making). However, consistent with prior reviews,27,28 
our taxonomy includes attention to evaluating outcomes 
of engagement and further differentiates and structures 
engagement process metrics. As a result, the identified metrics 
provide finer-grained details about both process and outcome 
evaluation aspects pertaining to P2C2 engagement.
Existing Tools Measuring P2C2 Engagement
The identified tools varied methodologically and reflected 
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Table 2. Coding Frequencies of Outcome Metrics in the Taxonomy per Evaluation Tool
Metric 
Tool Number (see Table 1)
234 335,36 538 639 740 841 942 1245 1447 1749 1950 2051 2151
* Outcome metric √ √ √√ √√√ √ √√ √ √ √ √ √√ √√ √√
Internal outcomes metrics
** Impact on engagement participants’  √√ √√ √ √   √√ √√  
Knowledge  √ √    √ √  
Skills  √ √       
Empowerment  √     √   
Satisfaction  √ √    √ √  
Trust    √     √  
** Impact on services provided  √ √  √ √  √
Efficiency and cost-effectiveness of services   √      
Service availability  √ √      
Services quality and safety   √  √ √   
Services responsiveness to needs   √     
Utilization of services   √    
** Impact on organization or system  √√ √√√ √ √  √√
Accountability of organization to P2C2 served   √   
Staff views on engagement    √ √
Formal (written) organization or system policies    √  
Explicit change to organization or system process of decision-making    √
Additional connections or partnerships with other groups or organizations  √ √ √
Funding and resources availability  √ √  
Visibility of organization   √  
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External outcomes metrics
** Influence on broader public’s  √  √
Awareness or knowledge of health issues  √   
Support of the organization or system  √  √
** Influence on population health √ √ √
Level of health inequalities √   
Population health status   √
Aggregate outcome: Overall cost-effectiveness of engagement  √
Filled out by:  External Evaluator E
                        *** Leader L L L L L L L L L L L
                        *** P2C2 representative R R R R R R R R R
Abbreviation: P2C2; patient, public, consumer and community.
KEY: √ 1-3 instances, √√ 4-14 instances, √√√ 15 or more instances of coding.
* Row includes instances of items coded only into the outcome metric category when further specification was not possible.
** Row include instances of items coded only into the subdomain when further specification was not possible.
*** Individual coded items could be asked of only leaders, only representatives or both; data shown are for tool as whole.
Metrics absent from all evaluation tools include, by metric subdomain:
- Impact on engagement participants’: (1) views; (2) confidence and self-esteem; (3) sense of ownership. 
- Impact on services provided: (1) number of complaints on services; (2) sustainability of the services; (3) user experiences with services.
- Impact on organization or system: (1) presence of racism in system; (2) informal (unwritten) organization or system procedures; (3) staff recruitment; (4) staff training; (5) level of public reporting; (6) number of local employment 
positions supported by organization; (7) organization ability to adapt to operative environment; (8) scale of engagement program by organization; (9) redesign of staff roles; (10) staff satisfaction; (11) sustainability of engagement 
initiative; (12) diversity of funding sources.
- Influence on broader public’s: (1) capacity for future involvement in the organization by the community; (2) level of control over decisions made by the organization or system; (3) involvement as part of social change outside the 
organization; (4) stigmatization of others.
Table 2. Continued
Metric 
Tool Number (see Table 1)
234 335,36 538 639 740 841 942 1245 1447 1749 1950 2051 2151
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Table 3. Coding Frequencies of Process Metrics in the Taxonomy Per Evaluation Tool
Metric
Tool Number (see Table 1)
133 234 335,36 437 538 639 740 841 942 1043 1144 1245 1346 1447 1547 1648 1749 1849 1950 2051 2151 2252 2353
* Process metric √√ √√ √√ √√ √√ √√√ √√ √√√ √√√ √ √√ √√√ √ √√√ √√ √√ √√√ √√ √√√ √√ √√ √√ √
Direct process 
metrics
** P2C2 participants’ control over decision process: √ √√ √ √ √ √ √√ √√√ √√√ √ √ √√ √ √ √ √ √√ √ √ √√ √√ √ √
Agenda setting and time allocation √            √ √   √ √      
Roles in decision-making are defined      √√ √       √  √ √ √    √  
Independence in decision-making             √           
Involvement since first stage of decision process         √   √ √        √   
Involvement throughout types of decision activities √  √ √  √   √√√ √ √√ √ √ √√  √ √ √   √  √
Involvement throughout stages of decision process   √     √     √        √   
Perceived influence on decision-making process  √√   √ √  √√      √   √  √ √√    
Involvement in finalizing decisions             √           
Control over the meeting minutes              √   √       
Assurance of follow-up commitment/translation into action               √      √√   
Evaluation of the decision-making process   √  √  √ √√ √   √ √  √    √ √    
Revision process (for changing decisions or handling 
complaints)
  √                     
Surrogate process 
metrics
** Formal powera   √ √     √ √ √  √ √ √ √ √ √      
 ** Organizational commitment to engagementa  √√  √ √ √√ √ √ √√ √  √√    √√  √   √√   
** Participation:  √√   √ √√ √  √ √   √ √ √  √  √    √
Activeness of participation            √          √
Equality of participation (among P2C2 participants)  √  √ √    √      √ √    
Attendance of engagement participants         √          
Regularity of meetings       √  √ √  √  √     
P2C2 participants’ readiness and attitudes towards engagement  √ √ √ √           
** Tailoring the engagement to P2C2 participants   √        
Cultural beliefs and practices √
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Preconditions 
for engagement 
metrics
P2C2-initiated engagement  √                    
** Recruitment and membership:   √        √ √√ √ √ √ √   √ √  
Method of recruitment   √        √ √  √ √ √   √ √  
Number of P2C2 members and P2C2 versus non-P2C2 
participant ratio
           √ √  √ √      
Time or terms mandate for membership            √          
** Representativeness and accountability:  √ √ √     √  √ √  √ √ √  √ √   
Constituent representativeness and accountability  √ √        √   √     √   
Democratic representativeness  √         √           
Diversity representativeness   √ √     √     √    √ √   
** Resources provided to P2C2 participants, among thema: √√  √ √ √√  √√ √ √ √ √ √√  √ √√ √ √√ √√ √√ √  
Support for disseminating results of the engagement    √     √ √  √   √ √   √√ √  
Use of a broader P2C2 needs and strengths assessment to 
support P2C2 representatives in their decision-making
  √                   
Unbiased, jargon-free information on which to make decisions √          √ √   √ √  √    
** Training (for P2C2 participants)a       √√    √ √ √ √ √ √ √     
** Training (for staff)a        √ √ √    √     √   
Aggregate 
process metrics
Respect     √         √    √    
Transparency of the decision-making process                  √ √ √  
Trust      √            √    
Level of participation           √          √
Filled out by:  External Evaluator E E   E  E  E    E  
                          Leader***  L L L L L L L L L L L L L L  L  L  L
                          P2C2 representative***  R R R R R R R   R  R R    
Abbreviation: P2C2; patient, public, consumer and community.
KEY: √ 1-3 instances, √√ 4-14 instances, √√√ 15 or more instances of coding.
* Row includes instances of items coded only into the outcome metric category when further specification was not possible.
** Row include instances of items coded only into the subdomain when further specification was not possible.
*** Individual coded items could be asked of only leaders, only representatives or both; data shown are for tool as whole.
a For brevity not all coded metrics are shown. For the full list of metrics, see the table in online Supplementary file 5. 
Some metrics were absent from all evaluation tools. These are available in Supplementary file 5. 
Table 3. Continued
Metric
Tool Number (see Table 1)
133 234 335,36 437 538 639 740 841 942 1043 1144 1245 1346 1447 1547 1648 1749 1849 1950 2051 2151 2252 2353
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greater emphasis on processes as compared to outcomes. 
Measuring outcomes of engagement is difficult in part 
because there may or may not be a proven causal connection 
between engagement and outcomes of interest. Consequently, 
many tools rely on measuring perceived benefits of 
engagement. However, meaningful engagement is more than 
mere perception; real outcomes (ie, documented changes 
in policies, procedures, or programs) should be preferred 
over perceived ones (ie, whether engagement participants or 
leaders believe they are making a difference). At the same time, 
the absence of real outcomes in tools may not be surprising; 
evaluating certain real outcomes (eg, cost) may not require a 
tool per se when this information is available by other means. 
Finally, several tools highlight how qualitative methods can 
complement the assessment of engagement process. 
It is important to note metrics which are underemphasized 
or absent from all tools. Regarding outcomes, improved trust 
in the organization may be widely perceived as a potential 
benefit of P2C2 engagement,58 but it was only measured 
by two tools. Neither did any tool measure sustainability 
of engagement (understood as the ability to maintain 
engagement with specific P2C2 participants over time) or 
the capacity to increase or scale engagement in other parts of 
the healthcare organization or system. Regarding processes, 
agenda-setting and time allocation decisions, which are 
considered key aspects of P2C2 engagement59 that help 
mitigate power imbalances, were evaluated in only five tools, 
and P2C2 participants’ involvement in finalizing decisions 
was evaluated in only one. Debate intensity, which was 
proposed in the 1970s as a measure of consumer input,60 was 
completely absent. 
Our findings add to prior reviews23,27-29,61 in important ways. 
Expanding the date range of our search identified additional 
evaluation tools. Four of the 23 tools were published in 
2015, suggesting that this is an area of active research and 
development, and three tools were available before 1990. 
A notable example is Steckler and Dawson,34 who in 1978 
published an evaluation of consumer participation in US 
Health Systems Agencies (HSAs). HSAs were geographically 
defined agencies that made decisions about healthcare 
planning and resource use and were legislatively required 
to have consumer participation.62 Steckler and Dawson’s 
evaluation relied on a structured questionnaire and interview 
data from both consumer participants and staff leaders. 
Practice, Policy and Research Implications
Our systematic review has implications for the implementation 
of P2C2 engagement and for future research. For those 
seeking to evaluate P2C2 engagement in real-world settings, 
several tools exist to get started. They vary methodologically, 
with some methods (eg, qualitative interviews and analysis) 
requiring more time, resources and expertise than others. 
Although, in our view, no evaluation tool is perfect and a 
comprehensive mapping of tools to all possible engagement 
contexts would be beyond the scope of this review, we were 
able to make three observations and practical suggestions 
to help potential evaluators in choosing among tools using 
Tables 2 and 3. 
First, in certain healthcare contexts, significant emphasis 
may be placed on whether P2C2 engagement demonstrates 
positive impact via quantitatively-measured outcomes (such 
as improving individuals’ knowledge or improving healthcare 
service quality, among others). In those contexts, two tools 
stand out in Table 2 as being most comprehensive in the 
area of outcomes.38,39 Second, while most included tools paid 
significant attention to process measures, again two stood out 
in Table 3. One was a quantitative assessment tool46 used for 
healthcare programs and based on the decades of work from 
Rifkin and colleagues,35 and another was a more qualitative 
assessment designed for individual hospitals in the United 
States.47 Third, it is important to note that some tools should 
be used together. For instance, the Participant questionnaire 
and Organization questionnaire of the Public and Patient 
Engagement Evaluation tool together provide a mixed method 
evaluation that is capable of assessing the perspectives of both 
P2C2 representatives and organizational leaders in different 
contexts.51
We can also interpret our taxonomy of metrics, which was 
developed inductively from the literature through the lens 
of Arnstein’s “ladder of participation.”56 This theoretical 
approach characterizes levels of engagement (ranging from, 
eg, manipulation to information to partnership to citizen 
control) and suggests that the goal of engagement is to 
increase P2C2 control over the decision process. Through 
Arnstein’s lens, we can suggest what may be the essential 
components of evaluation and how to advance evaluation 
over time (Figure 3).
These suggestions are tailored to a healthcare system or 
organization’s level of maturity for P2C2 engagement. First, 
although completely defining the discrete levels of maturity 
is beyond the scope of this paper, implicit in this figure 
(Figure 3) is the idea that systems or organizations should 
endeavor to progress from Level 1 (basic maturity, ie, ready to 
involve P2C2 participants) to Level 2 (intermediate maturity, 
ie, some experience with P2C2 engagement) to Level 3 (fully 
mature, ie, significant experience). Second, even though some 
tools identified in our review included only the system or 
organization leaders’ perspectives, in our view, any evaluation 
must solicit the P2C2 perspective on engagement, and when 
systems or organizations evaluate cost-effectiveness, they 
should include the time and resource costs accruing to P2C2 
participants. Third, as organizations become more mature, 
relative emphasis on different process and outcome metrics 
changes. For instance, mature systems and organizations 
should shift away from surrogate measures of P2C2 
participants control over decision-making toward direct 
control measures; likewise, they should be more attentive 
to external outcomes. Finally, as systems and organizations 
mature, they should consider using external evaluators, who 
could yield additional insights into the P2C2 engagement 
process.
From our review we suggest three priority areas of future 
research. First, additional research is needed to better 
understand the validity and reliability of tools and metrics in 
different healthcare contexts. The lack of evidence of rigorous 
testing of the identified tools for methodological quality and 
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psychometric properties was noticeable; it suggests a need 
to increase testing and reporting of these factors. Second, 
our taxonomy and the diversity of metrics employed by the 
tools argue for a consensus-building process to identify and 
disseminate core metrics. Our taxonomy provides a starting 
point for that process, which itself must include P2C2 
participants. As research into valid and reliable engagement 
metrics proceeds, attention will need to turn to comparative 
evaluation of the metrics (eg, to find the best way to 
measure representativeness) and the use of those metrics for 
comparative evaluation of different methods of engagement 
(eg, single representatives versus patient councils). Finally, 
new tools may be needed in order to capture parts of the 
taxonomy not currently represented in existing tools.
Strengths and Limitations
This review has several strengths. The search strategy was 
designed to be as broad and inclusive as possible in both 
terminology and date range. The resulting taxonomy was 
constructed not from any single theoretical approach to 
P2C2 engagement but instead from an inductive data-driven 
analysis and comprehensive literature review. Moreover, the 
findings from this review may inform other fields of P2C2 
engagement; for example, the identified process metrics 
might be of interest to those evaluating P2C2 engagement in 
research, environmental or other social policy settings. 
Like all studies, ours has limitations. First, we focused on 
organization-, community-,  and system-level decision-making 
in healthcare administration and organization. We excluded 
engagement, for instance, in other health-related fields, such 
as public health, health promotion or health education, and 
in other non-health fields. These were excluded to focus our 
review, and because existing engagement frameworks consider 
engagement in organization-, community-, and system-level 
decisions as a conceptually distinct activity from engagement 
in more societal-level decisions.2 While the translation of 
evaluation concepts and tools from these other fields could 
be possible and useful, that task is beyond the scope of this 
systematic review. Second, although our search strategy was 
designed to be comprehensive, certain terms (such as “health 
system”) may have different meanings in different countries 
and contexts. This could have affected our results. Moreover, 
terminology surrounding P2C2 engagement is imprecise (eg, 
patients versus consumers versus community members), and 
at present there appears to be no consensus regarding the 
aims and objectives of this type of engagement. This presents 
challenges to a literature search and systematic review. For 
instance, “community” engagement may be distinct from 
“patient” engagement in some circumstances (eg, when 
a healthcare organization wants to engage directly with a 
community that has historical distrust of that organization). 
Finally, because our review employed qualitative analysis, 
it may have introduced subjectivity in our categorization of 
metrics. 
Conclusions
Significant progress is being made in the evaluation of P2C2 
engagement in healthcare organization- and system-level 
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decision-making. The comprehensive taxonomy developed 
here suggests that organizations have ample process and 
outcome metrics as well as evaluation tools from which to 
choose when evaluating engagement efforts. Future research 
is needed to compare existing tools in practice, to develop 
new tools to capture all relevant metrics, and to use these 
tools to compare the effectiveness of different methods of 
engagement. This review lays the foundation for doing so.
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